Zobrazeno 1 - 10
of 756
pro vyhledávání: '"T-SPOT.TB"'
Publikováno v:
Frontiers in Microbiology, Vol 15 (2024)
BackgroundThe clinical challenge of differentiating suspected tuberculosis with positive T-SPOT.TB results persist. This study aims to investigate the utility of the Systemic Immune-Inflammation Index (SII), Fibrinogen, and T-SPOT.TB in distinguishin
Externí odkaz:
https://doaj.org/article/b2911e2f48f14f8c910d6272bbd3f5cc
Publikováno v:
Monaldi Archives for Chest Disease (2024)
Similar clinical features make the differential diagnosis difficult, particularly between lung cancer and pulmonary tuberculosis (TB), without pathological evidence for patients with concomitant TB infection. Our study aimed to build a nomogram to pr
Externí odkaz:
https://doaj.org/article/3f7e3829d68b42129c7a2f0ac6f5d8dd
Autor:
Thara Venkatappa, Dan Shen, Aurimar Ayala, Rongxia Li, Yoseph Sorri, Rose Punnoose, Dolly Katz
Publikováno v:
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, Vol 33, Iss , Pp 100386- (2023)
Background: Close contacts infected with Mycobacterium tuberculosis are at high risk of tuberculosis (TB) disease and a priority for preventive treatment. Three tests measure infection: two interferon-gamma release assays (IGRAs) and the tuberculin s
Externí odkaz:
https://doaj.org/article/4da93420658a406a966217fc4a66d8b2
Publikováno v:
Infection and Drug Resistance, Vol Volume 15, Pp 7077-7093 (2022)
Yidan Sun,1– 3,* Xiaozhou Yao,1– 3,* Yingmeng Ni,1– 3 Yibing Peng,4 Guochao Shi1– 3 1Department of Pulmonary and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic
Externí odkaz:
https://doaj.org/article/a66f5ad66d824702a432b2b32d6a32db
Autor:
Lifan Zhang, Yanan Ma, Nan Jiang, Xiaoqing Zou, Yueqiu Zhang, Fengchun Zhang, Xiaofeng Zeng, Yan Zhao, Shengyun Liu, Xiaoxia Zuo, Huaxiang Wu, Lijun Wu, Hongbin Li, Zhiyi Zhang, Sheng Chen, Ping Zhu, Miaojia Zhang, Wencheng Qi, Yi Liu, Huaxiang Liu, Xiaochun Shi, Xiaoqing Liu
Publikováno v:
Microbiology Spectrum, Vol 11, Iss 3 (2023)
ABSTRACT The objectives of this study were to screen for latent tuberculosis infection (LTBI) among patients with systemic lupus erythematosus (SLE) using the T-SPOT.TB assay and to identify factors affecting the assay results. SLE patients were enro
Externí odkaz:
https://doaj.org/article/12b3b15ad385418f83de2bfb9d53091c
Autor:
Dmitry A. Kudlai, N. P. Doktorova
Publikováno v:
Инфекция и иммунитет, Vol 12, Iss 3, Pp 439-449 (2022)
Recombinant technologies have been long widely used in medicine. This article presents a review on the application of medical technologies based on ESAT-6 and CFP-10 proteins in diagnostics and prevention of tuberculosis. ESAT-6 and CFP-10 are specif
Externí odkaz:
https://doaj.org/article/75e4b803bc104b1d935872e0def5304a
Publikováno v:
Clinical, Cosmetic and Investigational Dermatology, Vol Volume 15, Pp 1119-1123 (2022)
Zhen-Zhen Wang,1 Hongsheng Wang1,2 1Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Jiangsu Key Laboratory of Molecular Biology for Skin Diseases and STIs, Nanjing, People’s Republic of China; 2Center f
Externí odkaz:
https://doaj.org/article/5647c859d88046cea3f0faa3e887fc24
Publikováno v:
Acta Biomedica Scientifica, Vol 7, Iss 2, Pp 83-90 (2022)
Background. Tuberculosis associated with HIV infection is becoming almost a new disease, where not only new approaches to treatment are being formed, but there is also a need to improve the quality and search for new means of early diagnosis of tuber
Externí odkaz:
https://doaj.org/article/58e6dc7eeea345d5b8f6db351b31a94c
Publikováno v:
Diagnostics, Vol 13, Iss 14, p 2369 (2023)
Hemodialysis (HD) patients should be screened for latent tuberculosis (TB) infection. We aimed to determine the frequency of latent TB infection in HD patients and to compare the effectiveness of the tests used. The files of 56 HD patients followed b
Externí odkaz:
https://doaj.org/article/63348b3a72974ac0a22fb36b097608f6
Autor:
Chisato Kamimaki, Nobuaki Kobayashi, Momo Hirata, Kohei Somekawa, Nobuhiko Fukuda, Sousuke Kubo, Seigo Katakura, Shuhei Teranishi, Keisuke Watanabe, Nobuyuki Horita, Yu Hara, Masaki Yamamoto, Makoto Kudo, Hongmei Piao, Takeshi Kaneko
Publikováno v:
Thoracic Cancer, Vol 12, Iss 11, Pp 1726-1734 (2021)
Abstract Background Immune checkpoint inhibitors are a standard treatment for advanced lung cancer, although it remains important to identify biomarkers that can accurately predict treatment response. Immune checkpoint inhibitors enhance the antitumo
Externí odkaz:
https://doaj.org/article/d84a8207a6c34ec28c0240f6c21be844